Genetic Signatures: Allison Rossiter

Allison Rossiter has been appointed CEO of Australian molecular diagnostics firm Genetic Signatures. She takes over from Interim CEO Neil Gunn, who will remain with the company as non-executive director. The previous CEO, John Melki, stepped down in April. Rossiter most recently served as managing director of Roche Diagnostics' Australia business and she previously worked as the global lifecycle leader for molecular point-of-care products for US-based Roche Molecular Systems.